Biotech Intel



Aloe Finance Inc.
Latest Comments
image_pdfimage_print

Patent pending cannabinoid compounds bring new treatments to market


November 14, 2017
| November 14, 2017

Cannabinoids, the diverse compounds which bind to the homonymous receptors in the human body, are only recently being properly explored, […]


Graphene oxide to help reconnect human nerve cells…


November 02, 2017
| November 02, 2017

Nerves and their connections are the wiring in our bodies that connect brain to muscles. When this goes wrong we […]


Carbon Dioxide Delivery Technology Provides BlueOcean Market Advantage


October 31, 2017
| October 31, 2017

BlueOcean NutraSciences Inc. (TSXV: BOC) (“BlueOcean”) announced that it is shifting focus toward carbon dioxide (CO2) grow-solutions gas infusion business to […]


Scythian to treat the secondary effects of traumatic brain injuries with cannabinoids


August 14, 2017
| August 14, 2017 | 3 Comments

Scythian BioSciences Corp. (TSXV: SCYB), which began trading on the TSXV last week under the symbol SCYB, is developing cannabinoid-based drugs to […]


BlueOcean’s Pure Polar on its way to Europe


June 21, 2017
| June 21, 2017

BlueOcean NutraSciences Inc. (TSXV: BOC) (“BlueOcean”) announced that it has received its first order from a distributor in the European Union […]


IntelGenX on the way to take some of the $16bn thin films market


June 08, 2017
| June 08, 2017

As a technophile, IntelGenX Technologies Corp. (TSXV: IGX | OTCQX: IGXT) (“IntelGenX”) have always intrigued me. The company developed a […]


BlueOcean Nutraceuticals Inc.